Methods to increase the effectiveness of cytoreductive surgical interventions in patients with complicated disseminated tumors of the abdominal cavity and pelvis

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The expediency of performing two-stage cytoreductive interventions in patients with complicated disseminated tumors of the abdominal cavity and pelvis is presented. Ninety-two patients with complicated disseminated tumors of the abdominal cavity and pelvis were examined into two groups. The main group consisted of 33 patients who received surgical treatment by two-stage cytoreductive surgery. The control group included 59 patients who underwent single-stage cytoreductive operations. In both groups, life-threatening complications were dominated by primary tumor necrosis (main group, n = 15; control group, n = 31) and impaired intestinal patency (main group, n = 12; control group, n = 16, respectively). The average Charlson comorbidity index was 7.85 ± 1.37 and 7.53 ± 1.5 points, respectively. Anesthetic risk of grades III–IV according to the classification of the American Society of Anesthesiologists was detected in 23 (69.7%) and 45 (76.27%) patients of the main and control groups, respectively. Functional status of 2–3 points on the Eastern Cooperative Oncological Group was established in 23 (69.7%) and 46 (77.9%) patients of the main and control groups, respectively. The peritoneal carcinomatosis index was significantly higher in the main group (13.1 ± 6 vs 9.9 ± 4.8 points) than in the control group (p = 0.012). A comparative analysis of the results obtained in the treatment of the main and control groups demonstrated that the two-stage cytoreductive surgical interventions can reduce the frequency of postoperative complications, primarily Clavien–Dindo grades III–IV from 40.7 to 18.2% (p = 0.049) and mortality from 16.9% to 9.1% (p = 0.468) and increase the frequency of achieving complete cytoreduction from 49.1% to 90.9% (p = 0.002) and the frequency of intraperitoneal hyperthermic chemoperfusion from 40.7 to 93.9% (p < 0.001). Thus, two-stage cytoreductive surgical interventions are a safe and effective technique in the surgical treatment of complicated disseminated tumors of the abdominal cavity and pelvis.

作者简介

Van Thu Nguyen

Kirov Military Medical Academy

编辑信件的主要联系方式.
Email: thuhvqy@gmail.com
ORCID iD: 0000-0002-5546-2371
SPIN 代码: 6895-5893

adjunct

越南, Saint Petersburg

Vadim Prosvetov

Kirov Military Medical Academy

Email: thuhvqy@gmail.com
ORCID iD: 0000-0002-5503-1598
SPIN 代码: 1717-7735

resident

俄罗斯联邦, Saint Petersburg

Boris Bromberg

Kirov Military Medical Academy

Email: thuhvqy@gmail.com
ORCID iD: 0000-0001-9940-7772
SPIN 代码: 4567-6403

MD, Cand. Sci. (Med.)

俄罗斯联邦, Saint Petersburg

Denis Dymnikov

Kirov Military Medical Academy

Email: thuhvqy@gmail.com
ORCID iD: 0000-0003-1644-1014
SPIN 代码: 6945-7148

MD, Cand. Sci. (Med.)

俄罗斯联邦, Saint Petersburg

Vladimir Loginov

Kirov Military Medical Academy

Email: www.exclusive@mail.ru
ORCID iD: 0000-0002-2100-6087
SPIN 代码: 8481-7599

MD, Cand. Sci. (Med.), associate professor

俄罗斯联邦, Saint Petersburg

Andrey Demko

Kirov Military Medical Academy; Saint Petersburg Scientific Research Institute of Ambulance named after I.I. Janelidze

Email: demko@emergency.spb.ru
ORCID iD: 0000-0002-5606-288X
SPIN 代码: 3399-8762

MD, Dr. Sci. (Med.), professor

俄罗斯联邦, Saint Petersburg; Saint Petersburg

Ivan Solovеv

Kirov Military Medical Academy; Mariinskaya Hospital

Email: ivsolov@yandex.ru
ORCID iD: 0000-0001-9646-9775
SPIN 代码: 6703-4852

MD, Dr. Sci. (Med.), professor

俄罗斯联邦, Saint Petersburg; Saint Petersburg

Dmitry Surov

Kirov Military Medical Academy; Saint Petersburg Scientific Research Institute of Ambulance named after I.I. Janelidze

Email: thuhvqy@gmail.com
ORCID iD: 0000-0002-4519-0018
SPIN 代码: 5346-1613

MD, Dr. Sci. (Med.), associate professor

俄罗斯联邦, Saint Petersburg; Saint Petersburg

参考

  1. Sakhin VT, Madzhanova ER, Kryukov EV, et al. Pathogenetic characteristics of anemia in patients with solid tumors. Clinical oncohematology. 2017;10(4):514–518. (In Russ.). doi: 10.21320/2500-2139-2017-10-4-514-518
  2. Ferguson HJM, Ferguson CI, Speakman J, Ismail T. Management of intestinal obstruction in advanced malignancy. Ann Med Surg (Lond). 2015;4(3):264–270. doi: 10.1016/j.amsu.2015.07.018
  3. Nguen VT, Bromberg BB, Novikova MV, et al. Using two-stage cytoreductive surgery in a patient with complicated progressive small intestinal cancer. Bulletin of Pirogov national medical and surgical center. 2022;17(3):142–147. (In Russ.) doi: 10.25881/20728255_2022_17_3_142
  4. Sugarbaker PH. Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review. Indian J Surg Oncol. 2019;10(1):3–23. doi: 10.1007/s13193-018-0856-1
  5. Mehta SS, Gelli M, Agarwal D, Goéré D. Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases. Indian J Surg Oncol. 2016;7(2):225–229. doi: 10.1007/s13193-016-0504-6
  6. Sugarbacker PН, Chang D. Result of treatment of 385 patients with peritoneal surface of appendiceal malignancy. Ann Surg Oncol. 1999;6(8):727–731. doi: 10.1007/s10434-999-0727-7
  7. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24(24):4011–4019. doi: 10.1200/JCO.2006.07.1142

补充文件

附件文件
动作
1. JATS XML

版权所有 © Nguyen V., Prosvetov V.A., Bromberg B.B., Dymnikov D.A., Loginov V.A., Demko A.E., Solovеv I.A., Surov D.A., 2023

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

##common.cookie##